Zenazocine
Tools
Actions
General
Print/export
Print/export
In other projects
Appearance
From Wikipedia, the free encyclopedia
This is an old revision of this page, as edited by Entranced98 (talk | contribs) at 02:05, 27 May 2022 (+sd). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Opioid analgesic
![]() | |
![]() | |
Clinical data | |
---|---|
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C23H35NO2 |
Molar mass | 357.538 g·mol−1 |
3D model (JSmol) | |
| |
|
Zenazocine (INN; WIN-42,964) is an opioid analgesic of the benzomorphan family which made it to phase II clinical trials before development was ultimately halted and it was never marketed.[1][2] It acts as a partial agonist of the μ- and δ-opioid receptors, with less intrinsic activity at the former receptor and more at the latter receptor (hence, it behaves more antagonistically at the former and more agonistically at the latter), and produces antinociceptive effects in animal studies.[1]
See also
References
- ^ a b Ward SJ, Pierson AK, Michne WF (February 1985). "Pharmacological profiles of tonazocine (Win 42156) and zenazocine (Win 42964)". Neuropeptides. 5 (4–6): 375–8. doi:10.1016/0143-4179(85)90032-0. PMID 2860595. S2CID 20674308.
- ^ Cotton R, James R (1985). "Chapter 3. Analgesics, Opioids and Opioid Receptors". In Bailey DM (ed.). Annual Reports in Medicinal Chemistry. Vol. 20. Academic Press. pp. 21–30. doi:10.1016/S0065-7743(08)61029-5. ISBN 978-0-12-040520-6.
μ-opioid (MOR) |
| ||||
---|---|---|---|---|---|
δ-opioid (DOR) |
| ||||
κ-opioid (KOR) |
| ||||
Nociceptin (NOP) |
| ||||
Others |
|